Med. praxi. 2025;22(3):187-191 | DOI: 10.36290/med.2025.038

Female sexual dysfunctions

MUDr. Pavel Turčan, Ph.D., FECSM, MUDr. Peter Kepič, MUDr. Jozef Hambálek, MUDr. Pavla Entnerová
Centrum MEDIOL, s. r. o., Klinika sexuologie a andrologie, Olomouc

This review provides an overview of a relatively wide range of female sexual dysfunctions. It focuses on their classification, etiology, risk factors, diagnosis, and treatment to be as practical and beneficial as possible for physicians in practice. Since female sexual dysfunctions often arise as a result of multiple factors simultaneously, their resolution can sometimes be more complex and usually requires the cooperation of several specialists in various medical fields and psychology. Treatment is always highly individualized. An integral part of treatment is ensuring a safe and trustworthy environment for the woman. In many cases, therapy for the couple as a whole is also recommended.

Keywords: female sexual dysfunctions, low sexual desire, arousal, pain during intercourse.

Received: April 13, 2025; Revised: May 12, 2025; Accepted: May 12, 2025; Published: June 26, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Turčan P, Kepič P, Hambálek J, Entnerová P. Female sexual dysfunctions. Med. praxi. 2025;22(3):187-191. doi: 10.36290/med.2025.038.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 26.6.2026

    References

    1. . Kershaw V, Jha S. Female sexual dysfunction. The Obstetrician & Gynaecologist. 2022;24(1):12-23. Go to original source...
    2. . Arthur SS, Dorfman CS, Massa LA, et al; editors. Managing female sexual dysfunction. Urologic oncology: seminars and original investigations; 2022: Elsevier. Go to original source...
    3. . Imprialos KP, Koutsampasopoulos K, Katsimardou A, et al. Female sexual dysfunction: a problem hidden in the shadows. Current pharmaceutical design. 2021;27(36):3762-74. Go to original source... Go to PubMed...
    4. . Reed MA. Female sexual dysfunction. Clin Plast Surg. 2022;49(4):495-504. Go to original source... Go to PubMed...
    5. . Abd El Salam S, Hassan HE, Hagar Kamal RA. Women's sexual dysfunction associated with cervical cancer. Journal of Applied Health Sciences and Medicine. 2021;1(2):12-27.
    6. . Hosseini SE, Ilkhani M, Rohani C, et al. Prevalence of sexual dysfunction in women with cancer: A systematic review and meta-analysis. International journal of reproductive biomedicine. 2022;20(1):1. Go to original source... Go to PubMed...
    7. . Salari N, Hasheminezhad R, Abdolmaleki A, et al. The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Neurological sciences. 2023;44(1):59-66. Go to original source... Go to PubMed...
    8. . Tavoli A, Tavoli Z, Effatpanah M, et al. Prevalence and associated risk factors for sexual dysfunction among postmenopausal women: a study from Iran. Women's Midlife Health. 2021;7:1-6. Go to original source... Go to PubMed...
    9. . Nappi RE, Di Ciaccio S, Genazzani AD. Prolactin as a neuroendocrine clue in sexual function of women across the reproductive life cycle: an expert point of view. Gynecological Endocrinology. 2021;37(6):490-6. Go to original source... Go to PubMed...
    10. . Barbagallo F, Cannarella R, Condorelli RA, et al. Thyroid diseases and female sexual dysfunctions. Sexual Medicine Reviews. 2024;12(3):321-33. Go to original source... Go to PubMed...
    11. . Arcos-Romero AI, Calvillo C; editors. Sexual health and psychological well-being of women: a systematic review. Healthcare; 2023: MDPI. Go to original source...
    12. . Parish SJ, Cottler-Casanova S, Clayton AH, et al. The evolution of the female sexual disorder/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD. Sexual Medicine Reviews. 2021;9(1):36-56. Go to original source... Go to PubMed...
    13. . Prabhu SS, Hegde S, Sareen S. Female sexual dysfunction: A potential minefield. Indian journal of sexually transmitted diseases and AIDS. 2022;43(2):128-34. Go to original source... Go to PubMed...
    14. . Dolan I, Filipenský P. Sexuální dysfunkce-diagnostika a možnosti řešení. Urologie Pro Praxi. 2022;23(3). Go to original source...
    15. . Rácová L, Weiss P. Sexuální distraktory. Česká a Slovenská Psychiatrie. 2023;119(4).
    16. . Rausch D, Rettenberger M. Predictors of sexual satisfaction in women: A systematic review. Sexual medicine reviews. 2021;9(3):365-80. Go to original source... Go to PubMed...
    17. . Chovanec M, Vrzáčková P, Turčan P, et al. Poruchy lubrikácie a aké máme liečebné možnosti. Psychiatr prax. 2016;17(2):79-82.
    18. . Fait T. Klimakterická pacientka v ambulanci praktického lékaře. Med. praxi. 2023;20(3).
    19. . Nappi RE, Tiranini L, Martini E, et al. Medical treatment of female sexual dysfunction. Urologic Clinics. 2022;49(2):299-307. Go to original source... Go to PubMed...
    20. . Di Carlo C, Cagnacci A, Murina F, et al. Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women. Expert Opinion on Pharmacotherapy. 2024;25(11):1541-54. Go to original source... Go to PubMed...
    21. . Uloko M, Rahman F, Puri LI, et al. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review. International Journal of Impotence Research. 2022;34(7):635-41. Go to original source... Go to PubMed...
    22. . Edinoff AN, Sanders NM, Lewis KB, et al. Bremelanotide for treatment of female hypoactive sexual desire. Neurology international. 2022;14(1):75-88. Go to original source... Go to PubMed...
    23. . Lee JH, Lee JE, Harsh V, et al. Pharmacotherapy for sexual dysfunction in women. Current Psychiatry Reports. 2022;24(2):99-109. Go to original source... Go to PubMed...
    24. . Hsiao S-M, Chang S-R. Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function. Journal of the Formosan Medical Association. 2024;123(6):710-5. Go to original source... Go to PubMed...
    25. . Martins JCC, Lucas ARCA, Costa JMM. The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review. Revista Brasileira de Ginecologia e Obstetrícia. 2024;46:e-rbgo49.
    26. . Tabatabaie NS, Borujeni FR, Tavakol Z, et al. The Effect of Yoga and Pelvic Floor Muscle Exercise on Sexual Function and Sexual Self-esteem of Reproductive-age Women: A Randomized Clinical Trial. International Journal of Community Based Nursing and Midwifery. 2024;12(3):188.
    27. . Ning S, Liu S, Chen X, et al. Acupuncture modification treatment for female sexual dysfunction: A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2023;291:29-33. Go to original source... Go to PubMed...
    28. . Sood R, Kuhle CL, Thielen JM, et al. Association of mindfulness with female sexual dysfunction. Maturitas. 2022;161:27-32. Go to original source... Go to PubMed...
    29. . Moser A, Ballard SM, Jensen J, et al. The influence of cannabis on sexual functioning and satisfaction. Journal of Cannabis Research. 2023;5(1):2. Go to original source... Go to PubMed...
    30. . Weinberger JM, Houman J, Caron AT, et al. Female sexual dysfunction: a systematic review of outcomes across various treatment modalities. Sexual medicine reviews. 2019;7(2):223-50. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.